4.6 Article

Adult Psychiatric Outcomes of Girls With Attention Deficit Hyperactivity Disorder: 11-Year Follow-Up in a Longitudinal Case-Control Study

期刊

AMERICAN JOURNAL OF PSYCHIATRY
卷 167, 期 4, 页码 409-417

出版社

AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/appi.ajp.2009.09050736

关键词

-

资金

  1. Abbott
  2. Alza
  3. AstraZeneca
  4. Bristol-Myers Squibb
  5. Celltech
  6. Cephalon
  7. Eli Lilly
  8. Esai
  9. Forest
  10. GlaxoSmithKline
  11. Gliatech
  12. Janssen Pharmaceuticals
  13. McNeil
  14. Merck
  15. NARSAD
  16. National Institute on Drug Abuse
  17. National Institute of Child Health and Human Development
  18. NIMH
  19. New River
  20. Novartis
  21. Noven
  22. Neurosearch
  23. Organon
  24. Otsuka
  25. Pfizer
  26. Pharmacia
  27. Prechter Foundation
  28. Shire
  29. Stanley Foundation
  30. UCB Pharma
  31. Wyeth
  32. Pediatric Psychopharmacology Philanthropy Fund

向作者/读者索取更多资源

Objective: Few follow-up studies have been conducted of girls with ADHD, and none have followed girls into adulthood. The authors sought to estimate the prevalence of psychopathology in girls with and without ADHD followed into young adulthood. Method: The authors conducted a longitudinal case-control study of 6- to 18-year-old girls with (N=140) and without (N=122) ADHD ascertained from psychiatric and pediatric sources. At the 11-year follow-up, 96 (69%) of the girls with ADHD and 91 (75%) of the comparison girls were reassessed (mean age=22 years). Participants were blindly assessed by structured diagnostic interviews. Results: Lifetime and 1-year risks for all composite categories of psychopathology were significantly greater in girls with ADHD grown up relative to comparison girls; lifetime hazard ratios were 7.2 (95% CI=4.0-12.7) for antisocial disorders, 6.8 (95% CI=3.7-12.6) for mood disorders, 2.1 (95% CI=1.6-2.9) for anxiety disorders, 3.2 (95% CI=2.0-5.3) for developmental disorders, 2.7 (95% CI=1.6-4.3) for addictive disorders, and 3.5 (95% CI=1.6-7.3) for eating disorders. For lifetime psychopathology, all six composite categories remained statistically significant after controlling for other baseline psychopathology. Except for addictive disorders, significant 1-year findings remained significant after controlling for baseline psychopathology. The 1-year prevalences of composite disorders were not associated with lifetime or 1-year use of ADHD medication. Conclusions: By young adulthood, girls with ADHD were at high risk for antisocial, addictive, mood, anxiety, and eating disorders. These prospective findings, previously documented in boys with ADHD, provide further evidence for the high morbidity associated with ADHD across the life cycle.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据